Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/2109

TR 349 Mouse Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                  DOWICIDE EC-7 PENTACHLOROPHENOL


NTP Experiment-Test: 05074-01                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/09/94
Route: DOSED FEED                                                                                                 Time: 06:47:16




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  87-86-5

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05074-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  DOWICIDE EC-7 PENTACHLOROPHENOL                              Date: 09/09/94  
Route: DOSED FEED                                                                                                 Time: 06:47:16  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        0 PPM        100 PPM      200 PPM      600 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          35           50           50           50                                     
  Early Deaths                                                                                                                      
    Natural Death                                      3           15           10           11                                     
    Moribund Sacrifice                                 3            6            2                                                  
    Drowned                                                         1                                                               
  Survivors                                                                                                                         
    Terminal Sacrifice                                29           28           38           39                                     
  Animals Examined Microscopically                    35           50           50           49                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Cecum                             (34)         (10)         (3)          (45)                                   
      Peyer's Patch, Hyperplasia, Lymphoid                                                    1 (2%)                                
   Intestine Large, Colon                             (34)         (13)         (4)          (47)                                   
      Parasite Metazoan                                                          1 (25%)                                            
   Intestine Small, Ileum                             (34)         (10)         (3)          (46)                                   
      Peyer's Patch, Hyperplasia, Lymphoid                                                    1 (2%)                                
   Liver                                              (34)         (50)         (49)         (48)                                   
      Basophilic Focus                                 1 (3%)                    1 (2%)                                             
      Clear Cell Focus                                 1 (3%)       2 (4%)       1 (2%)      13 (27%)                               
      Clear Cell Focus, Multiple                                                12 (24%)     13 (27%)                               
      Cytomegaly, Diffuse                                                                     1 (2%)                                
      Degeneration, Cystic                                                       6 (12%)      1 (2%)                                
      Hematopoietic Cell Proliferation, Multifocal    20 (59%)     37 (74%)     35 (71%)     45 (94%)                               
      Infarct                                          2 (6%)       2 (4%)                                                          
      Inflammation, Chronic Active, Diffuse                         4 (8%)      29 (59%)     47 (98%)                               
      Inflammation, Chronic Active, Focal                                        1 (2%)                                             
      Pigmentation, Multifocal                                      4 (8%)      32 (65%)     48 (100%)                              
      Bile Duct, Cyst                                                            1 (2%)       2 (4%)                                
      Bile Duct, Cyst, Multiple                                                  1 (2%)                                             
      Bile Duct, Hyperplasia, Multifocal                                         1 (2%)      40 (83%)                               
      Hepatocyte, Cytomegaly, Diffuse                              37 (74%)     49 (100%)    47 (98%)                               
      Hepatocyte, Cytomegaly, Focal                                 1 (2%)                                                          
      Hepatocyte, Necrosis, Acute, Diffuse                         21 (42%)     49 (100%)    48 (100%)                              
      Hepatocyte, Necrosis, Acute, Focal               2 (6%)       4 (8%)                                                          
   Mesentery                                                       (4)          (1)          (2)                                    
      Inflammation, Acute                                                        1 (100%)                                           
      Inflammation, Chronic Active                                  3 (75%)                                                         
   Pancreas                                           (34)         (16)         (7)          (46)                                   
      Hyperplasia, Lymphoid                                         1 (6%)                                                          
      Acinus, Atrophy                                  5 (15%)      1 (6%)                                                          
      Duct, Cyst                                       1 (3%)       1 (6%)                                                          
      Duct, Ectasia                                    2 (6%)                    1 (14%)                                            
      Duct, Hyperplasia                                1 (3%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05074-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  DOWICIDE EC-7 PENTACHLOROPHENOL                              Date: 09/09/94  
Route: DOSED FEED                                                                                                 Time: 06:47:16  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        0 PPM        100 PPM      200 PPM      600 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Duct, Inflammation, Chronic                      1 (3%)                                                                       
   Salivary Glands                                    (35)         (12)         (3)          (46)                                   
      Hyperplasia, Lymphoid                                                                   1 (2%)                                
   Stomach, Glandular                                 (33)         (13)         (5)          (47)                                   
      Necrosis, Acute, Focal                                        1 (8%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (35)         (14)         (5)          (48)                                   
      Inflammation, Chronic                            1 (3%)                                 1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland                                      (35)         (50)         (47)         (49)                                   
      Capsule, Cyst                                    1 (3%)                    1 (2%)                                             
      Capsule, Hyperplasia                            35 (100%)    49 (98%)     47 (100%)    49 (100%)                              
      Corticomedullary Junction, Cyst                                            2 (4%)                                             
   Adrenal Gland, Cortex                              (35)         (49)         (47)         (49)                                   
      Accessory Adrenal Cortical Nodule                             1 (2%)                                                          
      Cyst                                                          1 (2%)                                                          
      Degeneration, Fatty                                                                     2 (4%)                                
      Hematopoietic Cell Proliferation                 1 (3%)       1 (2%)                                                          
      Hyperplasia                                      2 (6%)       1 (2%)                                                          
      Hypertrophy                                      6 (17%)      2 (4%)       5 (11%)                                            
      Hypertrophy, Focal                                                         1 (2%)                                             
   Adrenal Gland, Medulla                             (35)         (49)         (46)         (49)                                   
      Hyperplasia                                      2 (6%)       1 (2%)       5 (11%)     17 (35%)                               
   Pituitary Gland                                    (32)         (17)         (9)          (44)                                   
      Pars Distalis, Cyst                              1 (3%)                                                                       
      Pars Distalis, Hyperplasia                      16 (50%)                   2 (22%)     19 (43%)                               
   Thyroid Gland                                      (34)         (14)         (4)          (46)                                   
      Inflammation, Chronic                            1 (3%)                                 1 (2%)                                
      Ultimobranchial Cyst                                                                    1 (2%)                                
      Follicle, Cyst                                   2 (6%)                    1 (25%)      2 (4%)                                
      Follicular Cell, Hyperplasia                     5 (15%)                                5 (11%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05074-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  DOWICIDE EC-7 PENTACHLOROPHENOL                              Date: 09/09/94  
Route: DOSED FEED                                                                                                 Time: 06:47:16  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        0 PPM        100 PPM      200 PPM      600 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Ovary                                              (34)         (24)         (17)         (48)                                   
      Angiectasis                                      2 (6%)                                                                       
      Hyperplasia, Tubular                                                       1 (6%)                                             
      Inflammation, Chronic Active                     3 (9%)       8 (33%)      4 (24%)                                            
      Follicle, Cyst                                  11 (32%)      7 (29%)     10 (59%)     12 (25%)                               
      Periovarian Tissue, Cyst                         3 (9%)       3 (13%)      5 (29%)      3 (6%)                                
   Uterus                                             (34)         (36)         (41)         (47)                                   
      Angiectasis                                                   1 (3%)                                                          
      Inflammation, Acute                                           4 (11%)      4 (10%)                                            
      Inflammation, Chronic Active                                  1 (3%)                    1 (2%)                                
      Thrombosis                                       2 (6%)                                                                       
      Endometrium, Hyperplasia, Cystic, Glandular,                                                                                  
           Multifocal                                 31 (91%)     30 (83%)     37 (90%)     40 (85%)                               
      Endometrium, Hyperplasia, Cystic, Multifocal,                                                                                 
           Reticulum Cell                                                        1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Blood                                                           (1)                                                              
      Lymphocytosis                                                 1 (100%)                                                        
   Bone Marrow                                        (35)         (13)         (5)          (48)                                   
      Femoral, Hyperplasia, Diffuse, Neutrophil                                  1 (20%)                                            
      Femoral, Hyperplasia, Neutrophil                              3 (23%)      1 (20%)                                            
      Femoral, Myelofibrosis                          13 (37%)                   1 (20%)     20 (42%)                               
   Lymph Node                                         (34)         (23)         (11)         (44)                                   
      Lumbar, Hematopoietic Cell Proliferation                                                1 (2%)                                
      Mediastinal, Hyperplasia, Lymphoid                            1 (4%)                                                          
      Mediastinal, Inflammation, Acute                              1 (4%)                                                          
      Mesenteric, Hematopoietic Cell Proliferation                  1 (4%)       4 (36%)      4 (9%)                                
      Mesenteric, Hematopoietic Cell Proliferation,                                                                                 
           Multifocal                                                                         3 (7%)                                
      Mesenteric, Hyperplasia, Lymphoid                1 (3%)                                                                       
      Renal, Hematopoietic Cell Proliferation                                                 1 (2%)                                
      Renal, Hyperplasia, Lymphoid                     1 (3%)                                                                       
   Lymph Node, Mandibular                             (33)         (16)         (4)          (42)                                   
      Hyperplasia, Lymphoid                            1 (3%)       1 (6%)                    2 (5%)                                
      Pigmentation, Diffuse                            1 (3%)                                                                       
   Spleen                                             (34)         (26)         (17)         (47)                                   
      Depletion Lymphoid                                                                      1 (2%)                                
      Hemorrhage                                                                 1 (6%)                                             
      Hyperplasia, Lymphoid                                         1 (4%)                    2 (4%)                                
      Necrosis                                         1 (3%)                    1 (6%)                                             
      Red Pulp, Hematopoietic Cell Proliferation,                                                                                   
           Diffuse                                     1 (3%)       8 (31%)      5 (29%)      5 (11%)                               
   Thymus                                             (30)         (9)          (5)          (43)                                   
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05074-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  DOWICIDE EC-7 PENTACHLOROPHENOL                              Date: 09/09/94  
Route: DOSED FEED                                                                                                 Time: 06:47:16  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        0 PPM        100 PPM      200 PPM      600 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Degeneration, Acute                              1 (3%)                                                                       
      Inflammation, Acute                                                        1 (20%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (33)         (6)          (7)          (40)                                   
      Hyperplasia, Cystic                             19 (58%)      2 (33%)                  31 (78%)                               
   Skin                                               (35)         (22)         (18)         (46)                                   
      Alopecia                                         5 (14%)      1 (5%)       7 (39%)      2 (4%)                                
      Ulcer                                                                                   1 (2%)                                
      Sebaceous Gland, Hyperplasia                                                            1 (2%)                                
      Subcutaneous Tissue, Inflammation, Chronic                                                                                    
          Active                                                                              1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (35)         (14)         (5)          (49)                                   
      Femur, Hyperostosis                                                                     1 (2%)                                
      Joint, Tarsal, Hyperostosis                                                1 (20%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (35)         (14)         (5)          (47)                                   
      Compression                                      1 (3%)                                                                       
      Meninges, Infiltration Cellular, Lymphocyte      6 (17%)                                5 (11%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (35)         (15)         (6)          (48)                                   
      Hyperplasia, Lymphoid                                                                   2 (4%)                                
      Alveolar Epithelium, Hyperplasia                 1 (3%)                                 1 (2%)                                
      Interstitium, Inflammation, Chronic Active                                 1 (17%)                                            
      Mediastinum, Inflammation, Acute                                           2 (33%)                                            
   Nose                                               (35)         (14)         (5)          (48)                                   
      Glands, Inflammation, Acute, Focal                                         2 (40%)     46 (96%)                               
      Olfactory Epithelium, Metaplasia, Focal          1 (3%)                    2 (40%)     45 (94%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05074-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  DOWICIDE EC-7 PENTACHLOROPHENOL                              Date: 09/09/94  
Route: DOSED FEED                                                                                                 Time: 06:47:16  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE FEMALE                        0 PPM        100 PPM      200 PPM      600 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                             (1)                                                              
      Atrophy                                                       1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (34)         (15)         (8)          (48)                                   
      Infarct                                                                                 1 (2%)                                
      Nephropathy, Chronic                             3 (9%)                                 3 (6%)                                
      Glomerulus, Amyloid Deposition, Diffuse                       1 (7%)                                                          
      Glomerulus, Inflammation, Chronic, Diffuse                                              1 (2%)                                
      Renal Tubule, Dilatation                                      1 (7%)                                                          
      Renal Tubule, Regeneration                       2 (6%)                                 5 (10%)                               
   Urinary Bladder                                    (34)         (12)         (5)          (47)                                   
      Dilatation                                                    1 (8%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05074-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  DOWICIDE EC-7 PENTACHLOROPHENOL                              Date: 09/09/94  
Route: DOSED FEED                                                                                                 Time: 06:47:16  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          0 PPM        100 PPM      200 PPM      600 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          35           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                 2            3            4            6                                     
    Natural Death                                      8           19           17            9                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                25           28           29           35                                     
  Animals Examined Microscopically                    35           50           50           49                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Rectum                            (31)         (6)          (8)          (47)                                   
      Prolapse                                                                                1 (2%)                                
   Liver                                              (35)         (48)         (48)         (49)                                   
      Basophilic Focus                                 1 (3%)       3 (6%)                    2 (4%)                                
      Clear Cell Focus                                              2 (4%)                    4 (8%)                                
      Clear Cell Focus, Multiple                                   17 (35%)     21 (44%)     15 (31%)                               
      Degeneration, Cystic                                          2 (4%)       1 (2%)                                             
      Hematopoietic Cell Proliferation, Diffuse                     1 (2%)                                                          
      Hematopoietic Cell Proliferation, Multifocal     1 (3%)      20 (42%)     16 (33%)     40 (82%)                               
      Hyperplasia, Focal                                            2 (4%)       3 (6%)                                             
      Infarct                                          2 (6%)       1 (2%)       1 (2%)       2 (4%)                                
      Inflammation, Acute                              1 (3%)                                                                       
      Inflammation, Chronic Active, Diffuse                        36 (75%)     44 (92%)     43 (88%)                               
      Pigmentation, Multifocal                                     40 (83%)     37 (77%)     45 (92%)                               
      Thrombosis, Multiple                                          1 (2%)                                                          
      Bile Canaliculi, Hyperplasia, Atypical,                                                                                       
          Diffuse                                                   1 (2%)                                                          
      Bile Duct, Cyst                                               2 (4%)       3 (6%)       1 (2%)                                
      Bile Duct, Cyst, Multifocal                                                2 (4%)                                             
      Bile Duct, Cyst, Multiple                                     2 (4%)                                                          
      Bile Duct, Hyperplasia, Multifocal               1 (3%)       3 (6%)       5 (10%)     32 (65%)                               
      Hepatocyte, Cytomegaly, Diffuse                              48 (100%)    48 (100%)    47 (96%)                               
      Hepatocyte, Necrosis, Acute, Diffuse                         47 (98%)     47 (98%)     46 (94%)                               
      Hepatocyte, Necrosis, Acute, Focal               1 (3%)                                                                       
   Pancreas                                           (34)         (12)         (14)         (49)                                   
      Acinus, Atrophy                                  2 (6%)       1 (8%)                                                          
      Acinus, Degeneration                                                                    1 (2%)                                
      Acinus, Inflammation, Chronic                                                           1 (2%)                                
      Duct, Ectasia                                                 1 (8%)                                                          
   Stomach, Forestomach                               (33)         (11)         (15)         (49)                                   
      Acanthosis                                                    1 (9%)                    2 (4%)                                
      Hyperkeratosis                                                1 (9%)                                                          
      Inflammation, Acute                              1 (3%)                                                                       
      Inflammation, Chronic Active                                                            1 (2%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05074-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  DOWICIDE EC-7 PENTACHLOROPHENOL                              Date: 09/09/94  
Route: DOSED FEED                                                                                                 Time: 06:47:16  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          0 PPM        100 PPM      200 PPM      600 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Ulcer                                                         1 (9%)                    1 (2%)                                
   Stomach, Glandular                                 (33)         (11)         (15)         (49)                                   
      Dysplasia                                                                               3 (6%)                                
      Ulcer, Acute                                     1 (3%)                                                                       
   Tooth                                                                                     (3)                                    
      Developmental Malformation                                                              1 (33%)                               
      Peridontal Tissue, Inflammation, Chronic                                                                                      
          Active                                                                              2 (67%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (35)         (13)         (17)         (49)                                   
      Degeneration, Chronic                                                      1 (6%)                                             
      Mineralization                                   1 (3%)                                                                       
      Atrium, Thrombosis                                                         1 (6%)       2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland                                      (34)         (48)         (49)         (49)                                   
      Capsule, Ectopic Tissue                          3 (9%)                                                                       
      Capsule, Hyperplasia                            30 (88%)     34 (71%)     34 (69%)     29 (59%)                               
   Adrenal Gland, Cortex                              (34)         (48)         (48)         (49)                                   
      Cyst                                             1 (3%)                                                                       
      Cytoplasmic Alteration                                        1 (2%)                                                          
      Hematopoietic Cell Proliferation                              1 (2%)                                                          
      Hyperplasia                                      6 (18%)      7 (15%)      1 (2%)       1 (2%)                                
      Hypertrophy                                      4 (12%)      3 (6%)       6 (13%)      1 (2%)                                
   Adrenal Gland, Medulla                             (34)         (48)         (48)         (49)                                   
      Hyperplasia                                      1 (3%)      19 (40%)     13 (27%)      1 (2%)                                
   Pituitary Gland                                    (29)         (9)          (14)         (38)                                   
      Pars Distalis, Cyst                              1 (3%)                                                                       
   Thyroid Gland                                      (35)         (11)         (14)         (48)                                   
      Follicle, Cyst                                   1 (3%)                                                                       
      Follicular Cell, Hyperplasia                     3 (9%)                                 2 (4%)                                
      Follicular Cell, Hypertrophy                                  1 (9%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05074-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  DOWICIDE EC-7 PENTACHLOROPHENOL                              Date: 09/09/94  
Route: DOSED FEED                                                                                                 Time: 06:47:16  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          0 PPM        100 PPM      200 PPM      600 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (35)         (13)         (18)         (49)                                   
      Granuloma Sperm                                                                         1 (2%)                                
      Spermatocele                                                  1 (8%)                                                          
   Penis                                              (6)          (6)          (1)          (4)                                    
      Inflammation, Acute                                                                     1 (25%)                               
      Inflammation, Chronic Active                     3 (50%)      1 (17%)      1 (100%)                                           
   Preputial Gland                                    (3)          (8)          (4)          (4)                                    
      Dilatation                                                    1 (13%)                                                         
      Hyperplasia                                                   1 (13%)                                                         
      Inflammation, Chronic Active                     1 (33%)      6 (75%)      4 (100%)     4 (100%)                              
      Duct, Dilatation                                 2 (67%)      2 (25%)                   2 (50%)                               
   Prostate                                           (34)         (11)         (15)         (49)                                   
      Inflammation, Acute                                           1 (9%)       3 (20%)                                            
      Inflammation, Chronic Active                     1 (3%)       1 (9%)       1 (7%)                                             
   Seminal Vesicle                                    (1)          (3)          (2)          (1)                                    
      Dilatation                                                    2 (67%)                                                         
      Inflammation, Chronic Active                     1 (100%)     1 (33%)                                                         
   Testes                                             (35)         (12)         (18)         (49)                                   
      Inflammation, Chronic Active                     1 (3%)                                                                       
      Germinal Epithelium, Degeneration                                                       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Blood                                              (3)                       (1)                                                 
      Neutrophilia                                     3 (100%)                  1 (100%)                                           
   Bone Marrow                                        (35)         (10)         (14)         (49)                                   
      Femoral, Hyperplasia, Diffuse, Neutrophil                     1 (10%)                                                         
      Femoral, Hyperplasia, Neutrophil                 2 (6%)       1 (10%)      1 (7%)                                             
   Lymph Node                                         (31)         (14)         (22)         (47)                                   
      Angiectasis                                                   1 (7%)                                                          
      Hyperplasia, Plasma Cell                                      1 (7%)                                                          
      Lumbar, Hyperplasia, Lymphoid                    1 (3%)                                                                       
      Mesenteric, Hematopoietic Cell Proliferation     5 (16%)      4 (29%)     10 (45%)     10 (21%)                               
      Mesenteric, Hematopoietic Cell Proliferation,                                                                                 
           Multifocal                                  1 (3%)       1 (7%)                                                          
      Mesenteric, Hyperplasia, Lymphoid                                                       1 (2%)                                
      Pancreatic, Inflammation, Chronic Active         1 (3%)                                                                       
   Lymph Node, Mandibular                             (31)         (8)          (13)         (47)                                   
      Depletion Lymphoid                                                         1 (8%)                                             
      Hyperplasia, Lymphoid                                                                   1 (2%)                                
      Necrosis                                                                   1 (8%)                                             
   Spleen                                             (34)         (19)         (20)         (49)                                   
      Angiectasis                                      1 (3%)                                                                       
      Cyst                                                          1 (5%)                                                          
      Depletion Lymphoid                               5 (15%)      3 (16%)      6 (30%)      2 (4%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05074-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  DOWICIDE EC-7 PENTACHLOROPHENOL                              Date: 09/09/94  
Route: DOSED FEED                                                                                                 Time: 06:47:16  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          0 PPM        100 PPM      200 PPM      600 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Necrosis                                                                   1 (5%)                                             
      Red Pulp, Hematopoietic Cell Proliferation,                                                                                   
           Diffuse                                     5 (15%)      8 (42%)      7 (35%)      7 (14%)                               
   Thymus                                             (21)         (5)          (11)         (27)                                   
      Necrosis, Acute                                                                         1 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (34)         (32)         (26)         (49)                                   
      Acanthosis                                       3 (9%)       3 (9%)       1 (4%)      10 (20%)                               
      Alopecia                                         5 (15%)      8 (25%)      2 (8%)      12 (24%)                               
      Cyst Epithelial Inclusion                                     1 (3%)                                                          
      Hyperkeratosis                                                1 (3%)                                                          
      Inflammation, Acute                              1 (3%)                                                                       
      Inflammation, Chronic Active                                               1 (4%)                                             
      Metaplasia, Focal, Osseous                       1 (3%)                                                                       
      Necrosis                                         1 (3%)                                                                       
      Ulcer                                            2 (6%)       5 (16%)      4 (15%)      5 (10%)                               
      Ulcer, Focal                                                               1 (4%)                                             
      Subcutaneous Tissue, Fibrosis                                                           1 (2%)                                
      Subcutaneous Tissue, Inflammation, Acute                                   2 (8%)       2 (4%)                                
      Subcutaneous Tissue, Inflammation, Chronic                    1 (3%)                                                          
      Subcutaneous Tissue, Inflammation, Chronic                                                                                    
          Active                                       2 (6%)       3 (9%)       5 (19%)      2 (4%)                                
      Subcutaneous Tissue, Mineralization                                                     1 (2%)                                
      Subcutaneous Tissue, Necrosis, Acute                                       1 (4%)                                             
      Subcutaneous Tissue, Lymphatic, Dilatation       3 (9%)                                 1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (35)         (36)         (29)         (49)                                   
      Joint, Tarsal, Hyperostosis                     18 (51%)     26 (72%)     14 (48%)     12 (24%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (35)         (12)         (16)         (49)                                   
      Cyst Epithelial Inclusion                        1 (3%)                                                                       
      Meninges, Infiltration Cellular, Lymphocyte      1 (3%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05074-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  DOWICIDE EC-7 PENTACHLOROPHENOL                              Date: 09/09/94  
Route: DOSED FEED                                                                                                 Time: 06:47:16  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          0 PPM        100 PPM      200 PPM      600 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (35)         (15)         (19)         (49)                                   
      Alveolar Epithelium, Hyperplasia                 1 (3%)       1 (7%)                    2 (4%)                                
      Alveolar Epithelium, Hyperplasia, Focal                       1 (7%)                                                          
      Alveolar Epithelium, Bronchiole, Hyperplasia                                            1 (2%)                                
      Peribronchiolar, Glands, Inflammation, Acute                                            1 (2%)                                
      Perivascular, Infiltration Cellular,                                                                                          
          Lymphocyte                                                                          2 (4%)                                
   Nose                                               (35)         (13)         (16)         (49)                                   
      Glands, Inflammation, Acute, Focal               4 (11%)      1 (8%)       3 (19%)     47 (96%)                               
      Nasolacrimal Duct, Inflammation, Acute, Focal                 1 (8%)                    2 (4%)                                
      Olfactory Epithelium, Atrophy                                              1 (6%)                                             
      Olfactory Epithelium, Metaplasia, Focal          2 (6%)       1 (8%)       2 (13%)     46 (94%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                             (1)                       (1)                                    
      Cornea, Hyperplasia, Focal                                    1 (100%)                                                        
      Lens, Cataract                                                                          1 (100%)                              
   Harderian Gland                                    (27)         (12)         (13)         (35)                                   
      Inflammation, Chronic Active                                                            1 (3%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (35)         (14)         (20)         (49)                                   
      Cyst                                                                                    4 (8%)                                
      Hydronephrosis                                   1 (3%)       1 (7%)       1 (5%)                                             
      Infarct                                          1 (3%)                                                                       
      Inflammation, Acute                                           2 (14%)      1 (5%)                                             
      Inflammation, Chronic Active                     3 (9%)                    2 (10%)                                            
      Nephropathy, Chronic                             1 (3%)                                 1 (2%)                                
      Capsule, Fibrosis                                1 (3%)                                                                       
      Pelvis, Inflammation, Acute                                                1 (5%)                                             
      Renal Tubule, Dilatation                         3 (9%)                    2 (10%)      1 (2%)                                
      Renal Tubule, Dilatation, Diffuse                                          1 (5%)                                             
      Renal Tubule, Metaplasia, Osseous                                          1 (5%)                                             
      Renal Tubule, Mineralization                                               1 (5%)                                             
      Renal Tubule, Regeneration                      12 (34%)                               17 (35%)                               
   Urethra                                            (3)          (2)          (4)                                                 
      Calculus Micro Observation Only                  2 (67%)      1 (50%)      2 (50%)                                            
      Inflammation, Acute                                           1 (50%)      3 (75%)                                            
      Inflammation, Chronic Active                     1 (33%)                                                                      
   Urinary Bladder                                    (33)         (11)         (15)         (49)                                   
      Calculus Micro Observation Only                  1 (3%)                                                                       
      Dilatation                                       5 (15%)      3 (27%)      8 (53%)      3 (6%)                                
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05074-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  DOWICIDE EC-7 PENTACHLOROPHENOL                              Date: 09/09/94  
Route: DOSED FEED                                                                                                 Time: 06:47:16  
____________________________________________________________________________________________________________________________________
         B6C3F1 MICE MALE                          0 PPM        100 PPM      200 PPM      600 PPM                                   
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Inflammation, Acute                                           1 (9%)                                                          
      Inflammation, Chronic Active                     1 (3%)                    1 (7%)                                             
      Mucosa, Hyperplasia                              1 (3%)       1 (9%)       1 (7%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------                                           

--multipart-boundary
Content-type: text/plain
Range: bytes 73770-73770/73770


--multipart-boundary--